The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Cancer Cachexia: Mechanisms and Clinical Implications
Open accessAbstract
Cachexia is a multifactorial process of skeletal muscle and adipose tissue atrophy resulting in progressive weight loss. It is associated with poor quality of life, poor physical function, and poor prognosis in cancer patients. It involves multiple pathways: procachectic and proinflammatory signals from tumour cells, systemic inflammation in the host, and widespread metabolic changes (increased resting energy expenditure and alterations in metabolism of protein, fat, and carbohydrate). Whether it is primarily driven by the tumour or as a result of the host response to the tumour has yet to be fully elucidated. Cachexia is compounded by anorexia and the relationship between these two entities has not been clarified fully. Inconsistencies in the definition of cachexia have limited the epidemiological characterisation of the condition and there has been slow progress in identifying therapeutic agents and trialling them in the clinical setting. Understanding the complex interplay of tumour and host factors will uncover new therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
A role for ghrelin in the central regulation of feeding
Nakazato, M., Murakami, N., Date, Y., Kojima, M., Matsuo, H., Kangawa, K., & Matsukura, S. (2001) · Nature · doi:10.1038/35051587 · Cited by 3,443 · cited 1×
“Ghrelin induces the release of growth hormone, regulates appetite, and has antiinflammatory properties [129, 130].”
Evans, W. J., Morley, J. E., Argilés, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-Zadeh, K., Lochs, H., Mantovani, G., et al. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.06.013 · Cited by 2,450
Prognostic effect of weight loss prior tochemotherapy in cancer patients
Dewys, W. D., Begg, C., Lavin, P. T., Band, P. R., Bennett, J. M., Bertino, J. R., Cohen, M. H., Douglass, H. O., Engstrom, P. F., Ezdinli, E. Z., et al. (1980) · The American Journal of Medicine · doi:10.1016/s0149-2918(05)80001-3 · Cited by 2,354
Jonjić, S., Mutter, W., Weiland, F., Reddehase, M. J., & Koszinowski, U. H. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.4.1199 · Cited by 2,105
Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein
Ollmann, M. M., Wilson, B. D., Yang, Y.-K., Kerns, J. A., Chen, Y., Gantz, I., & Barsh, G. S. (1997) · Science · doi:10.1126/science.278.5335.135 · Cited by 1,881
Clinical Spectrum of Obesity and Mutations in the Melanocortin 4 Receptor Gene
Farooqi, I. S., Keogh, J. M., Yeo, G. S. H., Lank, E. J., Cheetham, T., & O'Rahilly, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022050 · Cited by 1,778
Tisdale, M. J. (2009) · Physiological Reviews · doi:10.1152/physrev.00016.2008 · Cited by 1,192
Moreira, A. L., Sampaio, E. P., Zmuidzinas, A., Frindt, P., Smith, K. A., & Kaplan, G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.6.1675 · Cited by 1,045
Systemic inflammation, nutritional status and survival in patients with cancer
McMillan, D. C. (2009) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32832a7902 · Cited by 1,001
Tisdale, M. J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc927 · Cited by 982
ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology
Arends, J., Bodoky, G., Bozzetti, F., Fearon, K., Muscaritoli, M., Selga, G., van Bokhorst-de van der Schueren, M. A. E., von Meyenfeldt, M., Zürcher, G., Fietkau, R., et al. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2006.01.020 · Cited by 930
Induction of Cachexia in Mice by Systemically Administered Myostatin
Zimmers, T. A., Davies, M. V., Koniaris, L. G., Haynes, P., Esquela, A. F., Tomkinson, K. N., McPherron, A. C., Wolfman, N. M., & Lee, S.-J. (2002) · Science · doi:10.1126/science.1069525 · Cited by 907
Andreyev, H. J. N., Norman, A. R., Oates, J., & Cunningham, D. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10090-9 · Cited by 797
Fearon, K. C., Voss, A. C., & Hustead, D. S. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1345 · Cited by 779
Maltoni, M., Caraceni, A., Brunelli, C., Broeckaert, B., Christakis, N., Eychmueller, S., Glare, P., Nabal, M., Viganò, A., Larkin, P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.866 · Cited by 664
Evidence for the involvement of interleukin 6 in experimental cancer cachexia.
Strassmann, G., Fong, M., Kenney, J. S., & Jacob, C. O. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115767 · Cited by 658
Reversal of Catabolism by Beta-Blockade after Severe Burns
Herndon, D. N., Hart, D. W., Wolf, S. E., Chinkes, D. L., & Wolfe, R. R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010342 · Cited by 639
Kamegai, J., Tamura, H., Shimizu, T., Ishii, S., Sugihara, H., & Wakabayashi, I. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2438 · Cited by 610
Fearon, K. C. H. (2003) · Gut · doi:10.1136/gut.52.10.1479 · Cited by 603
Ravasco, P., Monteiro-Grillo, I., Marques Vidal, P., & Camilo, M. E. (2005) · Head & Neck · doi:10.1002/hed.20221 · Cited by 575
Ravasco, P., Monteiro-Grillo, I., Vidal, P. M., & Camilo, M. E. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.054 · Cited by 564
Feinstein, R., Kanety, H., Papa, M. Z., Lunenfeld, B., & Karasik, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74276-8 · Cited by 549
Jatoi, A., Windschitl, H. E., Loprinzi, C. L., Sloan, J. A., Dakhil, S. R., Mailliard, J. A., Pundaleeka, S., Kardinal, C. G., Fitch, T. R., Krook, J. E., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.567 · Cited by 543
Melanocortin receptors in leptin effects
Seeley, R. J., Yagaloff, K. A., Fisher, S. L., Burn, P., Thiele, T. E., van Dijk, G., Baskin, D. G., & Schwartz, M. W. (1997) · Nature · doi:10.1038/37016 · Cited by 522
McMillan, D. C. (2008) · Proceedings of the Nutrition Society · doi:10.1017/s0029665108007131 · Cited by 472
Barber, M. D., Ross, J. A., Voss, A. C., Tisdale, M. J., & Fearon, K. C. H. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690654 · Cited by 459
Moses, A. W. G., Slater, C., Preston, T., Barber, M. D., & Fearon, K. C. H. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601620 · Cited by 452
Characterization of a cancer cachectic factor
Todorov, P., Cariuk, P., McDevitt, T., Coles, B., Fearon, K., & Tisdale, M. (1996) · Nature · doi:10.1038/379739a0 · Cited by 437
Cachexia Worsens Prognosis in Patients with Resectable Pancreatic Cancer
Bachmann, J., Heiligensetzer, M., Krakowski-Roosen, H., Büchler, M. W., Friess, H., & Martignoni, M. E. (2008) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-008-0505-z · Cited by 428
Falconer, J. S., Fearon, K. C. H., Plester, C. E., Ross, J. A., & Carter, D. C. (1994) · Annals of Surgery · doi:10.1097/00000658-199404000-00001 · Cited by 415
Strasser, F., Luftner, D., Possinger, K., Ernst, G., Ruhstaller, T., Meissner, W., Ko, Y.-D., Schnelle, M., Reif, M., & Cerny, T. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.1847 · Cited by 413
Kotler, D. P. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-8-200010170-00015 · Cited by 386
Bruera, E. D., Roca, E. L., Cedaro, L., Carraro, S., & Chacon, R. (1985) · PubMed · Cited by 348
Loprinzi, C. L., Kugler, J. W., Sloan, J. A., Mailliard, J. A., Krook, J. E., Wilwerding, M. B., Rowland, K. M., Camoriano, J. K., Novotny, P. J., & Christensen, B. J. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3299 · Cited by 343
Cancer anorexia-cachexia syndrome: are neuropeptides the key?
Inui, A. (1999) · PubMed · Cited by 342
Cancer: disease and nutrition are key determinants of patients? quality of life
Monteiro-Grillo, I., Vidal, P. M., Camilo, M. E., & Ravasco, P. (2004) · Supportive Care in Cancer · doi:10.1007/s00520-003-0568-z · Cited by 336
Reeds, P. J., Fjeld, C. R., & Jahoor, F. (1994) · The Journal of Nutrition · doi:10.1093/jn/124.6.906 · Cited by 335
Systemic inflammation, cachexia and prognosis in patients with cancer
Deans, C., & Wigmore, S. J. (2005) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000165004.93707.88 · Cited by 331
Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial
Gordon, J. N., Trebble, T. M., Ellis, R. D., Duncan, H. D., Johns, T., & Goggin, P. M. (2005) · Gut · doi:10.1136/gut.2004.047563 · Cited by 322
Fatty Acids as Modulators of the Immune Response
Fritsche, K. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.25.050304.092610 · Cited by 316
ABC of palliative care: Anorexia, cachexia, and nutrition
Bruera, E. (1997) · BMJ · doi:10.1136/bmj.315.7117.1219 · Cited by 311
Jatoi, A., Rowland, K., Loprinzi, C. L., Sloan, J. A., Dakhil, S. R., MacDonald, N., Gagnon, B., Novotny, P. J., Mailliard, J. A., Bushey, T. I. L., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.024 · Cited by 296
AGA technical review on parenteral nutrition
Koretz, R. L., Lipman, T. O., & Klein, S. (2001) · Gastroenterology · doi:10.1053/gast.2001.28031 · Cited by 296
Role of the central melanocortin system in cachexia.
Marks, D. L., LING, N. C., & Cone, R. D. (2001) · PubMed · Cited by 291
Bruera, E., Strasser, F., Palmer, J. L., Willey, J., Calder, K., Amyotte, G., & Baracos, V. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.101 · Cited by 287
Effect of Oral Eicosapentaenoic Acid on Weight Loss in Patients With Pancreatic Cancer
Wigmore, S. J., Barber, M. D., Ross, J. A., Tisdale, M. J., & Fearon, K. C. H. (2000) · Nutrition and Cancer · doi:10.1207/s15327914nc3602_6 · Cited by 275
Corticosteroid therapy of preterminal gastrointestinal cancer
Moertel, C. G., Schutt, A. J., Reitemeier, R. J., & Hahn, R. G. (1974) · Cancer · doi:10.1002/1097-0142(197406)33:6<1607::aid-cncr2820330620>3.0.co;2-v · Cited by 258
Dewey, A., Baughan, C., Dean, T. P., Higgins, B., & Johnson, I. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004597.pub2 · Cited by 257
Gélin, J., Moldawer, L. L., Lönnroth, C., Sherry, B. A., Chizzonite, R., & Lundholm, K. (1991) · PubMed · Cited by 251
Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients.
Hirai, K., Hussey, H., Barber, M. D., Price, S. A., & Tisdale, M. J. (1998) · PubMed · Cited by 244
Mantovani, G., Macciò, A., Madeddu, C., Serpe, R., Massa, E., Dessì, M., Panzone, F., & Contu, P. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0153 · Cited by 231
Jatoi, A., Ritter, H. L., Dueck, A., Nguyen, P. L., Nikcevich, D. A., Luyun, R. F., Mattar, B. I., & Loprinzi, C. L. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2009.06.020 · Cited by 212
Understanding and Managing Cancer Cachexia
MacDonald, N., Easson, A. M., Mazurak, V. C., Dunn, G. P., & Baracos, V. E. (2003) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(03)00382-x · Cited by 207
Megestrol acetate for treatment of anorexia-cachexia syndrome
Berenstein, G., & Ortiz, Z. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004310.pub2 · Cited by 206
Pathophysiology of cancer cachexia: Much more than host–tumour interaction?
Skipworth, R. J. E., Stewart, G. D., Dejong, C. H. C., Preston, T., & Fearon, K. C. H. (2007) · Clinical Nutrition · doi:10.1016/j.clnu.2007.03.011 · Cited by 197
Cancer anorexia-cachexia syndrome: cytokines and neuropeptides
Ramos, E. J., Suzuki, S., Marks, D., Inui, A., Asakawa, A., & Meguid, M. M. (2004) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/01.mco.0000134363.53782.cb · Cited by 196
Deans, D. A. C., Tan, B. H., Wigmore, S. J., Ross, J. A., de Beaux, A. C., Paterson-Brown, S., & Fearon, K. C. H. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604828 · Cited by 191
Goldberg, R. M., Loprinzi, C. L., Mailliard, J. A., O'Fallon, J. R., Krook, J. E., Ghosh, C., Hestorff, R. D., Chong, S. F., Reuter, N. F., & Shanahan, T. G. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.11.2856 · Cited by 184
Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome
Pascual López, A., Roqué i Figuls, M., Urrútia Cuchi, G., Graciela Berenstein, E., Almenar Pasies, B., Balcells Alegre, M., & Herdman, M. (2004) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2003.09.007 · Cited by 184
Prednisolone as an appetite stimulant in patients with cancer.
Willox, J. C., Corr, J., Shaw, J., Richardson, M., Calman, K. C., & Drennan, M. (1984) · BMJ · doi:10.1136/bmj.288.6410.27 · Cited by 180
DeBoer, M. D., Zhu, X. X., Levasseur, P., Meguid, M. M., Suzuki, S., Inui, A., Taylor, J. E., Halem, H. A., Dong, J. Z., Datta, R., et al. (2007) · Endocrinology · doi:10.1210/en.2007-0016 · Cited by 177
IGF-1 is downregulated in experimental cancer cachexia
Costelli, P., Muscaritoli, M., Bossola, M., Penna, F., Reffo, P., Bonetto, A., Busquets, S., Bonelli, G., Lopez-Soriano, F. J., Doglietto, G. B., et al. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00104.2006 · Cited by 175
Gridelli, C., Gallo, C., Ceribelli, A., Gebbia, V., Gamucci, T., Ciardiello, F., Carozza, F., Favaretto, A. G., Daniele, B., Galetta, D., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70146-8 · Cited by 169
Orr, R., & Fiatarone Singh, M. (2004) · Drugs · doi:10.2165/00003495-200464070-00004 · Cited by 167
Tisdale, M. J. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283347e77 · Cited by 166
Elevated energy expenditure in cancer patients with solid tumours
Hyltander, A., Drott, C., Körner, U., Sandström, R., & Lundholm, K. (1991) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(91)90050-n · Cited by 158
Role of Mononuclear Cells and Inflammatory Cytokines in Pancreatic Cancer-Related Cachexia
Martignoni, M. E., Kunze, P., Hildebrandt, W., Künzli, B. M., Berberat, P. O., Giese, T., Klöters, O., Hammer, J., Büchler, M. W., Giese, N. A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0185 · Cited by 157
Is there a role for melatonin in supportive care?
Lissoni, P. (2002) · Supportive Care in Cancer · doi:10.1007/s005200100281 · Cited by 152
Estimation of Cachexia among Cancer Patients Based on Four Definitions
Fox, K. M., Brooks, J. M., Gandra, S. R., Markus, R. A., & Chiou, C. (2009) · Journal of Oncology · doi:10.1155/2009/693458 · Cited by 147
Insulin Treatment in Cancer Cachexia: Effects on Survival, Metabolism, and Physical Functioning
Lundholm, K., Körner, U., Gunnebo, L., Sixt-Ammilon, P., Fouladiun, M., Daneryd, P., & Bosaeus, I. G. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2720 · Cited by 145
Elia, M., de van der Schueren, M. A. E., Garvey, J., Goedhart, A. C., Lundholm, K., Nitenberg, G., & Stratton, R. J. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.1.5 · Cited by 145
Matthys, P., Heremans, H., Opdenakker, G., & Billiau, A. (1991) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(91)90483-t · Cited by 141
Increased expression of proteasome subunits in skeletal muscle of cancer patients with weight loss
Khal, J., Hine, A. V., Fearon, K. C. H., Dejong, C. H. C., & Tisdale, M. J. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.017 · Cited by 141
Whitehouse, A., & Tisdale, M. J. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601132 · Cited by 140
Read, J. A., Beale, P. J., Volker, D. H., Smith, N. F., Childs, A., & Clarke, S. J. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0153-3 · Cited by 140
A placebo‐controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome
Jatoi, A., Dakhil, S. R., Nguyen, P., Sloan, J. A., Kugler, J. W., Rowland, K. M., Soori, G. S., Wender, D. B., Fitch, T. R., Novotny, P. J., et al. (2007) · Cancer · doi:10.1002/cncr.22944 · Cited by 138
Prognostic Factors in Advanced Gastrointestinal Cancer Patients With Weight Loss
O'Gorman, P., McMillan, D. C., & McArdle, C. S. (2000) · Nutrition and Cancer · doi:10.1207/s15327914nc3701_4 · Cited by 135
Cancer cachexia: the molecular mechanisms
Argilés, J. M. A., Moore‐Carrasco, R., Fuster, G., Busquets, S., & López-Soriano, F. J. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00251-0 · Cited by 132
Evans, W. K., Makuch, R., Clamon, G. H., Feld, R. D., Weiner, R. S., Moran, E. M., Blum, R., Shepherd, F. A., Jeejeebhoy, K. N., & DeWys, W. D. (1986) · Lung Cancer · doi:10.1016/s0169-5002(86)80124-6 · Cited by 123
Berk, L. B., James, J., Schwartz, A. L., Hug, E. B., Mahadevan, A., Samuels, M. A., & Kachnic, L. A. (2008) · Supportive Care in Cancer · doi:10.1007/s00520-008-0403-7 · Cited by 119
Lundholm, K., Daneryd, P., Körner, U., Hyltander, A. G., & Bosaeus, I. G. (2004) · International Journal of Oncology · doi:10.3892/ijo.24.3.505 · Cited by 119
Lissoni, P., Paolorossi, F., Ardizzoia, A., Barni, S., Chilelli, M. G., Mancuso, M., Tancini, G., Conti, A. M. F., & Maestroni, G. J. M. (1997) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1997.tb00329.x · Cited by 115
Mantovani, G., Macciò, A., Esu, S., Lai, P., Santona, M. C., Massa, E., Dessì, D., Melis, G. B., & Giacco, G. S. D. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00486-8 · Cited by 114
Dietary patterns in patients with advanced cancer: implications for anorexia-cachexia therapy
Hutton, J. L., Martin, L., Field, C. J., Wismer, W. V., Bruera, E. D., Watanabe, S., & Baracos, V. E. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.5.1163 · Cited by 112
C-Reactive Protein and All-Cause Mortality in a Large Hospital-Based Cohort
Marsik, C. L., Kazemi-Shirazi, L., Schickbauer, T., Winkler, S., Joukhadar, C., Wagner, O. F., & Endler, G. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.091959 · Cited by 112
Deans, D. A. C., Wigmore, S. J., Gilmour, H. M., Paterson‐Brown, S., Ross, J. A., & Fearon, K. C. H. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603446 · Cited by 110
Metabolic consequences of physical inactivity
Biolo, G., Ciocchi, B., Stulle, M., Piccoli, A., Lorenzon, S., Mas, V. D., Barazzoni, R., Zanetti, M., & Guarnieri, G. (2005) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2004.09.009 · Cited by 109
Ryall, J. G., & Lynch, G. S. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.06.003 · Cited by 104
Fouladiun, M., Körner, U., Gunnebo, L., Sixt-Ammilon, P., Bosaeus, I. G., & Lundholm, K. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1147 · Cited by 104
Watchorn, T., Waddell, I. D., Dowidar, N., & Ross, J. A. (2001) · The FASEB Journal · doi:10.1096/fj.00-0534fje · Cited by 102
Mantovani, G., Macciò, A., Madeddu, C., et al. (2008) · Nutrition · doi:10.1016/j.nut.2007.12.010 · Cited by 101
Markison, S., Foster, A. C., Chen, C., Brookhart, G., Hesse, A., Hoare, S. R. J., Fleck, B. A., Brown, B. T., & Marks, D. L. (2005) · Endocrinology · doi:10.1210/en.2005-0142 · Cited by 99
Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer
Chlebowski, R. T., Herrold, J. N., Ali, I., Oktay, E., Chlebowski, J. S., Ponce, A. T., Heber, D., & Block, J. B. (1986) · Cancer · doi:10.1002/1097-0142(19860701)58:1<183::aid-cncr2820580131>3.0.co;2-3 · Cited by 97
Hess, L. M., Barakat, R. R., Tian, C., Ozols, R. F., & Alberts, D. S. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.06.010 · Cited by 93
O'Gorman, P., McMillan, D. C., & McArdle, C. S. (1999) · Nutrition and Cancer · doi:10.1207/s15327914nc352_5 · Cited by 92
Dejong, C. H. C., Busquets, S., Moses, A. G. W., Schrauwen, P., Ross, J. A., Argilés, J. M. A., & Fearon, K. C. H. (2005) · Oncology Reports · doi:10.3892/or.14.1.257 · Cited by 90
Yasumoto, K., Mukaida, N., Harada, A., Kuno, K., Akiyama, M., Nakashima, E., Fujioka, N., Mai, M., Kasahara, T., & Fujimoto-Ouchi, K. (1995) · PubMed · Cited by 88
Dahele, M. R., Skipworth, R. J. E., Wall, L. R., Voss, A., Preston, T., & Fearon, K. C. H. (2007) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2006.09.024 · Cited by 88
Thalidomide and its derivatives: emerging from the wilderness
Gordon, J., & Goggin, P. M. (2003) · Postgraduate Medical Journal · doi:10.1136/pmj.79.929.127 · Cited by 86
Cancer cachexia: A therapeutic approach
Argilés, J. M. A., Meijsing, S. H., Pallarés‐Trujillo, J., Guirao, X., & López-Soriano, F. J. (2000) · Medicinal Research Reviews · doi:10.1002/1098-1128(200101)21:1<83::aid-med4>3.0.co;2-1 · Cited by 78
Beta-adrenoceptor activity and resting energy metabolism in weight losing cancer patients.
Hyltander, A., Daneryd, P., Sandström, R., Körner, U., & Lundholm, K. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00273-7 · Cited by 77
Catabolism of adipose tissue by a tumour-produced lipid-mobilising factor
Khan, S., & Tisdale, M. J. (1999) · International Journal of Cancer · Cited by 63
Novel treatment approaches to cachexia and sarcopenia: highlights from the 5th Cachexia Conference
Kung, T., Springer, J., Doehner, W., Anker, S. D., & von Haehling, S. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543781003724690 · Cited by 57
Body Cell Mass in Cancer‐Bearing and Anorexic Patients
Moley, J. F., Aamodt, R., Rumble, W. F., Kaye, W. H., & Norton, J. A. (1987) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607187011003219 · Cited by 57
Is There a Human Homologue to the Murine Proteolysis-Inducing Factor?
Wieland, B., Stewart, G. D., Skipworth, R. J. E., Sangster, K., Fearon, K. C. H., Ross, J. A., Reiman, T., Easaw, J., Mourtzakis, M., Kumar, V., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0946 · Cited by 57
Modulation of adipocyte G-protein expression in cancer cachexia by a lipid-mobilizing factor (LMF)
Islam-Ali, B. S., Khan, S., Price, S. A., & Tisdale, M. J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1992 · Cited by 55
Chance, W. T., Balasubramaniam, A., Thompson, H., Mohapatra, B. N., Ramo, J., & Fischer, J. E. (1996) · Peptides · doi:10.1016/0196-9781(96)00108-8 · Cited by 55
Diagnostic criteria of cachexia and their assessment: decreased muscle strength and fatigue
Strasser, F. (2008) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3283025e27 · Cited by 51
Characterization of a Human Homologue of Proteolysis-Inducing Factor and Its Role in Cancer Cachexia
Monitto, C. L., Dong, S.-M., Jen, J., & Sidransky, D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0435 · Cited by 50
Research methodology: cancer cachexia syndrome
Dahele, M. R., & Fearon, K. (2004) · Palliative Medicine · doi:10.1191/0269216304pm906ra · Cited by 49
Calpain-3 gene expression is decreased during experimental cancer cachexia
Busquets, S., Garcia‐Martínez, C., Alvarez, B., Carbó, N., López-Soriano, F. J., & Argilés, J. M. A. (2000) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(00)00050-7 · Cited by 38
Deans, C., Wigmore, S. J., Paterson‐Brown, S., Black, J., Ross, J. A., & Fearon, K. C. H. (2005) · Cancer · doi:10.1002/cncr.20972 · Cited by 35
Update on melanocortin interventions for cachexia: Progress toward clinical application
DeBoer, M. D. (2009) · Nutrition · doi:10.1016/j.nut.2009.07.003 · Cited by 35
Whitaker, K. W., & Reyes, T. M. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.10.014 · Cited by 26
Guarcello, M., Riso, S., Buosi, R., & D’Andrea, F. (2007) · Nutritional Therapy & Metabolism · Cited by 26
Protein synthesis in cancer patients with inflammatory response: investigations with [15N]glycine.
McMillan, D. C., Preston, T., Fearon, K. C. H., Burns, H. J. G., Slater, C., & Shenkin, A. (1994) · PubMed · Cited by 23
New strategies to overcome cancer cachexia: from molecular mechanisms to the 'Parallel Pathway'.
Muscaritoli, M., Costelli, P., Aversa, Z., Bonetto, A., Baccino, F. M., & Fanelli, F. R. (2008) · PubMed · Cited by 19
Basics in Clinical Nutrition: Nutritional support in cancer
Bozzetti, F. (2009) · e-SPEN the European e-Journal of Clinical Nutrition and Metabolism · doi:10.1016/j.eclnm.2009.06.018 · Cited by 17
Bosutti, A., Toigo, G., Ciocchi, B., Situlin, R., Guarnieri, G., & Biolo, G. (2002) · Clinical Nutrition · doi:10.1054/clnu.2002.0557 · Cited by 13
Agteresch, H. J., Rietveld, T., Kerkhofs, L., et al. (2004) · Nutrition in Clinical Practice · doi:10.1177/0115426504019004413 · Cited by 9
Lipton (1995) · Pure Amsterdam UMC · doi:10.1002/1097-0142(19950415)75:8 · Cited by 1
Cited by
Cancer and Inflammation: An Old Intuition with Rapidly Evolving New Concepts
Trinchieri, G. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075008 · Cited by 511
Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment
Ackerman, D., & Simon, M. C. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.06.001 · Cited by 495
Cancer cachexia, mechanism and treatment
Aoyagi, T., Terracina, K. P., Raza, A., Matsubara, H., & Takabe, K. (2015) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v7.i4.17 · Cited by 434
TNF-α and cancer cachexia: Molecular insights and clinical implications
Patel, H. J., & Patel, B. M. (2017) · Life Sciences · doi:10.1016/j.lfs.2016.11.033 · Cited by 342
Cancer cachexia—pathophysiology and management
Suzuki, H., Asakawa, A., Amitani, H., Nakamura, N., & Inui, A. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0787-0 · Cited by 268
Metadata
- Authors
- Donohoe, C. L., Ryan, A. M., & Reynolds, J. V.
- Venue
- Gastroenterology Research and Practice
- Publisher
- Hindawi Limited
- Published
- 2011
- Volume
- 2011
- Pages
- 1-13
- ISSN
- 1687-6121 (ISSN-L)
- 1687-630X
- OpenAlex
- W2028849454
- Cited by
- 273
- References
- 123
- FWCI
- 8.47
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.